Eukaryotic genomes are secluded within the nucleus, an organelle with a boundary that comprises the double-membraned nuclear envelope (NE) ([@r1]). The inner and outer bilayers of the NE are perforated by annular channels that contain nuclear pore complexes (NPCs), each a massive assembly that regulates the trafficking of macromolecules like mRNA and proteins between the cytoplasm and nucleoplasm. The evolution of the envelope, among other roles, helped safeguard genome duplication and mRNA transcription from parasitic nucleic acids ([@r2]). The isolation of nucleoplasm from cytoplasm, however, presents a challenge during cell division when duplicated chromosomes must be separated for daughter-cell inheritance.

Chromosome inheritance depends on assembly of a mitotic spindle, which pulls chromosomes toward opposite sides of the duplicating cell. Spindle assembly begins when two microtubule-organizing centers (MTOCs) nucleate polymerization of antiparallel arrays of microtubules to capture daughter chromosomes. Despite functional conservation throughout Eukarya, the mechanisms by which spindle microtubules breach the NE to gain access to metaphase chromosomes vary markedly ([@r3][@r4][@r5]--[@r6]). In vertebrates and other organisms that have an "open mitosis," the NE disassembles completely, so that nucleoplasmic identity is lost. Certain protists and fungi, by contrast, maintain NE integrity throughout a "closed mitosis" ([@r3], [@r5]).

The fission yeast *Schizosaccharomyces pombe* and the budding yeast *Saccharomyces cerevisiae* integrate their MTOC, known as the spindle pole body (SPB), into the NE so that microtubule assembly can occur in the nucleoplasm ([@r3], [@r4], [@r7], [@r8]). In budding yeast, duplication of the SPB is coupled with NE remodeling so that mother and daughter SPBs reside within the envelope throughout the cell cycle ([@r4], [@r9]). Fission yeast, by contrast, restrict SPB access to the nucleoplasm during mitosis only ([@r7], [@r8]). Upon mitotic entry, a fenestration through the NE opens transiently, and the mother and daughter SPBs are incorporated ([@r3], [@r5], [@r6], [@r8], [@r10]). For every cell cycle, therefore, the fission yeast NE must open and reseal twice: once when the SPBs are inserted and again when the SPB is ejected from the envelope after a successful cell cycle.

Incorporating NPCs and SPBs into the NE requires certain factors and mechanisms in common, including membrane-remodeling activities ([@r6], [@r11][@r12][@r13][@r14]--[@r15]). We and others have previously reported strong genetic interactions between transmembrane nucleoporins, SPB components, and endosomal sorting complexes required for transport (ESCRT) genes---portending a role for certain ESCRT proteins in nuclear membrane remodeling ([@r16], [@r17]). In general, ESCRT components are recruited to different target membranes by site-specific adaptors that ultimately recruit the membrane-remodeling ESCRT-III subunits and their binding partners, including VPS4-family adenosine triphosphatases (ATPases) ([@r18][@r19]--[@r20]). We previously showed that certain ESCRT-III mutants and *vps4Δ* cells displayed an apparent overamplification of SPBs (or defective fragments) in fission yeast and that the severity of this SPB phenotype in fission yeast waned over time, suggesting possible genetic suppression ([@r16]). In budding yeast, Webster et al. reported that, without ESCRT-III/Vps4 activity, misassembled NPCs accumulate in a compartment they named the SINC (for storage of improperly assembled NPCs) ([@r21]). They also showed that LEM family (Lap2-Emerin-Man1) inner nuclear membrane (INM) proteins Heh1p and Heh2p in budding yeast associate with defective NPC assembly intermediates (but not with mature NPCs) and that Heh1/2 proteins may recruit ESCRT-III and Vps4 activities to malformed NPCs to clear them from the NE ([@r21]).

In mammals, VPS4 depletion induces nuclear morphology defects ([@r22]), and several recent reports have demonstrated that ESCRT pathway proteins are recruited transiently to seal gaps in reforming mammalian nuclear membranes during anaphase ([@r23], [@r24]) and to rupture sites in the nuclei of interphase mammalian cells ([@r25], [@r26]). Depletion of ESCRT factors delays sealing of the reforming NE and impairs mitotic spindle disassembly ([@r23], [@r24]). Moreover, depletion of SPASTIN, another meiotic clade VPS4-family member and ESCRT-III--binding enzyme ([@r27]), also delays spindle disassembly and envelope resealing ([@r24], [@r28]). Similar effects were seen upon depletion of several ESCRT-III proteins, including the poorly characterized ESCRT factor CHMP7, which has features of both ESCRT-II and -III proteins ([@r29]). These observations support a model in which ESCRT-III and VPS4 proteins and SPASTIN together coordinate microtubule severing with the closure of annular gaps in the NE. This model is conceptually similar to the mechanism of cytokinetic abscission, where SPASTIN disassembles the residual microtubules that pass between daughter cells, while ESCRT-III and VPS4 proteins constrict the midbody membrane to the point of fission ([@r19], [@r28], [@r30]).

Here, we address the key question of what upstream factor(s) serves as the membrane-specific adaptor that facilitates CHMP7 recruitment to function in sealing NE breaches. To identify factors in this pathway, we returned to the genetically tractable fission yeast system. We report that deletion of *vps4* in *S. pombe* leads to severe defects in nuclear membrane morphology and nuclear integrity, with secondary defects in NPCs and SPB dynamics. Remarkably, these phenotypes are suppressed spontaneously when cells acquire loss-of-function mutations in *cmp7*, an ortholog of human CHMP7, or in *lem2*, a LEM domain INM protein and ortholog of human LEM2. We also show that, in human cells, recruitment of CHMP7 and downstream ESCRT-III proteins to the reforming NE during anaphase depends on LEM2, most likely through a direct interaction between CHMP7 and the C-terminal nucleoplasmic domain of LEM2. Together, these observations implicate LEM2 as a nucleus-specific adaptor that recruits ESCRT pathway activities to remodel the NE during both open and closed mitoses across Eukaryotes.

Results {#s1}
=======

*vps4*∆ Fission Yeast Cells Grow Very Slowly, and Loss of Either *cmp7* or *lem2* Rescues Growth. {#s2}
-------------------------------------------------------------------------------------------------

The AAA ATPase VPS4 has a primary role in disassembling ESCRT-III polymeric structures in the different settings where the ESCRT pathway mediates membrane remodeling. To determine whether and how reported phenotypes that result from deletion of VPS4 were suppressed over time ([@r16]), we monitored the growth of individual colonies after sporulation and tetrad dissection of *vps4Δ/+* diploid cells. Growth rates of *vps4Δ* spores were dramatically slower than wild-type (WT) spores ([Fig. 1*A*](#fig01){ref-type="fig"}). This growth defect spontaneously reverted over time, so that when mutant spores were streaked on rich medium, some *vps4Δ* colonies exhibited growth rates comparable to WT colonies ([Fig. 1*B*](#fig01){ref-type="fig"}). To identify potential suppressor mutations, we sequenced complete genomes for 12 strains that spontaneously reverted to WT growth rates and compared them with genomes of both WT and apparently unsuppressed *vps4Δ* strains. The analysis revealed that 7 of the 12 suppressors had different loss-of-function mutations in the ESCRT-II/-III hybrid gene, *cmp7* ([Table S1](#st01){ref-type="table"}). The remaining five each had equivalent independent mutations in a LEM domain family member, *lem2*, within what appears to be a slippery poly-T track ([Table S1](#st01){ref-type="table"}). These 12 mutant alleles were further confirmed by Sanger sequencing, and none of the suppressors were found to harbor mutations in both *cmp7* and *lem2* simultaneously.

![*vps4Δ* cells grow slowly and have severe NE defects, which are suppressed by loss of *cmp7* or *lem2.* (*A*) Tetrad dissection of *vps4Δ/+* diploids, with genotypes labeled below the image. (Scale bar: 0.25 cm.) (*B*) Spontaneous suppressors (arrowhead) of *vps4Δ* (arrow) appearing after 3 d on rich medium, with colony sizes comparable to those of WT cells. (Scale bar: 1 cm.) (*C*) Growth curves of each genotype showing optical densities of yeast cultures, starting at OD~600nm~ 0.06, for 32 h in 2-h intervals. Three independent isolates for each genotype were measured. The plots show mean ± SEM. (*D*) WT cells, showing normal NE morphologies (Ish1p-mCherry) and DNA (Hoechst staining) within the nuclei. (*E*) *vps4Δ*, showing various NE morphology defects including excess NE, fragmented NE, and DNA that appears to be outside of the nucleus. (Scale bar: 5 μm.) (*F*) Deletion of either *cmp7* or *lem2* rescues these NE morphology defects. Here and throughout, three independent isolates/strains were imaged for each genotype, and *n* represents the total number of scored cells. Mean ± SEM, WT: 1 ± 1%, *n* = 115, 121, 139; *vps4Δ*: 85 ± 5%, *n* = 62, 69, 86; *cmp7Δ*: 2.0 ± 0.4%, *n* = 151, 166, 147; *vps4Δcmp7Δ*: 1.1 ± 0.7%, n =161, 118, 145; *lem2Δ*: 8 ± 3%, n= 131, 103, 128; *vps4Δlem2Δ*: 12.2 ± 0.7%, *n* = 99, 176, 111. Two-tailed Student *t* tests were used here and throughout. \*\*\**P* \< 0.001.](pnas.1613916114fig01){#fig01}

###### 

Spontaneous suppressor alleles of *vps4Δ* identified in this study

  Suppressor                                     Suppressor mutation alleles                   Mutation     Total no. of valid reads   No. of supporting reads   Percentage of supporting reads, %   Residues affected                              Length of peptide translated, amino acids
  ---------------------------------------------- --------------------------------------------- ------------ -------------------------- ------------------------- ----------------------------------- ---------------------------------------------- -------------------------------------------
  *A. cmp*7[\*](#sitfn1){ref-type="table-fn"}                                                                                                                                                                                                       
   1                                             *cmp7-1*                                      Frameshift   26                         25                        96                                  24--449                                        24
   2                                             *cmp7-2*                                      Nonsense     35                         35                        100                                 W49[\*](#sitfn1){ref-type="table-fn"}(stop)    48
   3                                             *cmp7-3*                                      Nonsense     20                         19                        95                                  Q139[\*](#sitfn1){ref-type="table-fn"}(stop)   138
   4                                             *cmp7-4*                                      Frameshift   15                         15                        100                                 280--449                                       284
   5                                             *cmp7-5*                                      Frameshift   10                         10                        100                                 126--449                                       155
   6                                             *cmp7-6*                                      Frameshift   31                         31                        100                                 115--449                                       148
   7                                             *cmp7-7*                                      Frameshift   19                         19                        100                                 285--449                                       287
  *B. lem2*[^†^](#sitfn2){ref-type="table-fn"}                                                                                                                                                                                                      
   8                                             *lem2-1*[^‡^](#sitfn3){ref-type="table-fn"}   Frameshift   20                         20                        100                                 550--668                                       561
   9                                             *lem2-1*                                      Frameshift   17                         17                        100                                 550--668                                       561
   10                                            *lem2-1*                                      Frameshift   23                         23                        100                                 550--668                                       561
   11                                            *lem2-1*                                      Frameshift   22                         22                        100                                 550--668                                       561
   12                                            *lem2-1*                                      Frameshift   24                         23                        95                                  550--668                                       561

Whole-genome sequencing of WT (*n* = 2), *vps4Δ* mutant (*n* = 2), and spontaneous suppressors (*n* = 12) uncovered mutant alleles responsible for rescuing growth defects of *vps4Δ*.

WT *cmp7* encodes a peptide of 449 amino acids.

WT *lem2* encodes a peptide of 668 amino acids.

The *lem2-1* mutant allele had a single T inserted within a series of 7 T residues corresponding to nucleotides 1,643--1,649 (relative to the *lem2* ATG).

To determine whether these potentially suppressive alleles rescued the growth of *vps4Δ* cells, we engineered *cmp*7*Δ/+* and *lem2Δ/+* genotypes within our *vps4Δ/+* diploid background and isolated *lem2Δ*, *cmp7Δ*, and *vps4Δ* single mutants and their corresponding double mutants via sporulation and tetrad dissection. Quantitative growth rates in liquid culture for biological and technical triplicates demonstrated that *cmp7Δ* single mutants had WT growth rates and that the *vps4Δcmp7Δ* double-mutant cells grew much faster than *vps4Δ* single-mutant cells (albeit slightly more slowly than WT cells; [Fig. 1*C*](#fig01){ref-type="fig"}). Similarly, *lem2Δ* single mutants displayed a modest growth deficit compared with WT, but *vps4Δlem2Δ* double-mutant cells again grew much faster than *vps4Δ* cells ([Fig. 1*C*](#fig01){ref-type="fig"}). Thus, our unbiased whole-genome sequencing and targeted double-mutant studies demonstrate that *cmp7* and *lem2* are bona fide *vps4* suppressors and that the spontaneous mutations phenocopy null alleles.

*vps4*∆ Cells Have NE Defects, Which Are Suppressed by Loss of *cmp7* or *lem2*. {#s3}
--------------------------------------------------------------------------------

Next, we sought to discover the cellular defects that correlated with the slow growth of *vps4Δ* cells and to test whether those defects were also rescued by *cmp7Δ* or *lem2Δ*. In light of our prior work on mitotic and SPB defects in *vps4*∆ cells, we first examined NE and SPB morphology and dynamics. More than 80% of *vps4Δ* cells from recently dissected *vps4Δ* haploid spores displayed severe NE morphology defects. These defects were rescued by loss of either *cmp7* or *lem2* ([Fig. 1 *D*--*F*](#fig01){ref-type="fig"}). Moreover, ∼30% of *vps4Δ* cells displayed clearly asymmetric SPB segregation errors and anucleate daughter cells ([Fig. S1 *A* and *B*](#sfig01){ref-type="fig"}). In this case, loss of *cmp7* rescued these phenotypes, but loss of *lem2* did not. Indeed, even *lem2Δ* single-mutant cells displayed similar SPB segregation defects ([Fig. S1*C*](#sfig01){ref-type="fig"}). Thus, defects in NE morphology and integrity were the features that correlated best with the slow-growth phenotype, suggesting that these defects were primarily responsible for the *vps4Δ* slow-growth phenotype.

![*vps4*Δ and *lem2*Δ exhibit asymmetric SPB segregation. (*A*) WT cells showing symmetric SPB segregation. (*B*) *vps4Δ* showing asymmetric SPB segregation. (*C*) Quantified percentages of asymmetric SPB segregation events in each genotype. Cells with septa were selected and scored for SPB separation patterns. Nuclei were stained with Hoechst. WT: 0.7 ± 0.3%, *n* = 103, 101, 101; *vps4Δ*: 29 ± 7%, *n* = 88, 103, 107; *cmp7Δ*: 2 ± 1%, *n* = 105, 103, 101; *vps4Δcmp7Δ:* 4 ± 2%, n = 117, 100, 104; *lem2Δ*: 18 ± 1%, n = 102, 103, 100; *vps4Δlem2Δ*: 18 ± 4%, *n* = 102, 103, 101. \**P* \< 0.05. N.S., not significant. (Scale bar: 5 μm.)](pnas.1613916114sfig01){#sfig01}

*vps4Δ* Cells Display a Series of Mitotic Errors Associated with NE Defects. {#s4}
----------------------------------------------------------------------------

Live cell imaging using NE (Ish1p-mCherry) and SPB (Cut12p-YFP) markers enabled us to monitor the development and consequences of NE defects in mutant vs. WT cells. Abnormal NE morphologies or asymmetric and even failed karyokinesis were observed in the majority of cells ([Fig. 2](#fig02){ref-type="fig"}), and only ∼30% of *vps4Δ* cells displayed normal, symmetric karyokinesis ([Fig. 2*A*](#fig02){ref-type="fig"}). An apparent proliferation or overgrowth of Ish1p-marked membranes was a particularly common defect in *vps4Δ* cells. Approximately 25% of mutant cells displayed these long-lived NE "outgrowths" that we later determined were karmellae (see below). In cells with karmellae, daughter SPBs often failed to separate normally or displayed extensive delays in separation ([Fig. 2*B*](#fig02){ref-type="fig"}). Indeed, separation of duplicated SPBs was significantly prolonged in *vps4Δ* cells, whether or not they exhibited abnormal NE malformations ([Fig. S2](#sfig02){ref-type="fig"}). Together, these observations suggest that Vps4p plays a central role in regulating NE morphology in fission yeast, particularly during SPB extrusion or insertion through the NE, and perhaps during karyokinesis.

![*vps4Δ* cells display a series of mitotic defects associated with failure of nuclear membrane maintenance. (*A*) Time lapse of normal mitotic karyokinesis in *vps4Δ* cells. In all cases, the nuclear membrane is marked by Ish1p-mCherry, and the SPB is marked by Cut12p-YFP. The total length of time is 100 min. (*B*) Karmellae formation correlates with defective separation of duplicated SPB. The total length of time is 400 min. (*C*) Asymmetric nuclear division. Total length of time is 100 min. (*D*) Failed nuclear division. Total length of time is 100 min. (*E*) Quantification of NE morphology during mitosis in WT and *vps4Δ*. Normal mitotic nuclear division, WT: 99 ± 1%, *vps4Δ*: 27 ± 8%; karmellae formation, WT: 0%, *vps4Δ*: 29 ± 3%; asymmetric nuclear division, mean ± SEM, WT: 1 ± 1%, *vps4Δ*: 38 ± 2%; failed nuclear division, WT: 0%, *vps4Δ*: 6 ± 2%. WT, *n* = 23, 21, 18; *vps4Δ*, *n* = 43, 51, 84. \**P* \< 0.05; \*\*\**P* \< 0.001. (Scale bars: 5 μm.) (*A*--*D*) Dashed lines correspond with the cell wall.](pnas.1613916114fig02){#fig02}

![SPB separation is delayed in *vps4*Δ mutants. A 16-h time-lapse imaging (10-min intervals) was conducted on WT and *vps4Δ* cells at 32 °C, and the times required for SBP separation were scored. Data were binned and plotted by mean frequency ± SEM: WT: 10 min 96 ± 2%; 20--50 min 4 ± 2%; \>50 min 0%; *n* = 23, 22, 22; *vps4Δ*: 10 min 57 ± 4%; 20--50 min 31 ± 4%; \>50 min 12 ± 3%; *n* = 30, 30, 30. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](pnas.1613916114sfig02){#sfig02}

*vps4Δ* Nuclei Leak and Their Integrity Is Largely Restored by Loss of *cmp7* or *lem2*. {#s5}
----------------------------------------------------------------------------------------

Our observations, together with recent reports that the ESCRT pathway closes holes in the mammalian NE ([@r23], [@r24]), prompted us to test the integrity of *vps4Δ* nuclei. Image analysis revealed that a large nuclear import cargo, NLS-GFP-LacZ, was enriched within nuclei by \>10-fold in 98% of WT cells ([Fig. 3*A*](#fig03){ref-type="fig"}). By contrast, ∼55% of *vps4Δ* cells displayed \<10-fold nuclear enrichment (partial leaking; [Fig. 3*B*](#fig03){ref-type="fig"}, arrowheads), and ∼10% of *vps4Δ* cells displayed \<2-fold nuclear enrichment of NLS-GFP-LacZ (severe leaking; [Fig. 3*B*](#fig03){ref-type="fig"}, arrow; [Fig. 3 *C* and *D*](#fig03){ref-type="fig"}, quantification). Remarkably, loss of *cmp7* or *lem2* rescued this abnormal nuclear integrity phenotype to a large extent, although a small minority of single and double *cmp7* or *lem2* cells still displayed partial leaking ([Fig. 3 *C* and *D*](#fig03){ref-type="fig"}). Live cell imaging also revealed that the extent of nuclear integrity loss correlated with NE morphology defects ([Fig. S3](#sfig03){ref-type="fig"}). Cells that initially displayed normal GFP reporter localization and normal NE morphology gradually accumulated cytoplasmic signal over the course of tens of minutes ([Fig. S3*A*](#sfig03){ref-type="fig"}). Cells with abnormal NE morphology at the beginning of the experiment, by contrast, lost nuclear GFP completely over the time course ([Fig. S3*B*](#sfig03){ref-type="fig"}). Thus, cytoplasmic GFP resulted from loss of nuclear integrity rather than from defects in nuclear import.

![*vps4Δ* cells have leaky nuclei and nuclear integrity is restored by loss of either *cmp7* or *lem2*. (*A*) GFP signals in the nuclear lumen of WT cells expressing NLS-GFP-LacZ. (*B*) *vps4Δ* cells expressing NLS-GFP-LacZ with moderate (arrowheads) or severe (arrow) nuclear leaking. (Scale bar: 10 μm.) (*C*) Nuclear enrichment of NLS-GFP-LacZ (nucleus/cytoplasm). Mean ± SD, WT: 21.6 ± 8.9, *n* = 205; *vps4Δ*: 8.6 ± 4.7, *n* = 180; *cmp7Δ*: 19.4 ± 7.7, *n* = 175; *vps4Δcmp7Δ*: 24.5 ± 11.7, *n* = 202; *lem2Δ*: 19.1 ± 10.4, *n* = 198; *vps4Δlem2Δ*: 21.5 ± 8.8, *n* = 189. (*D*) Percentage of cells in different nuclear leaky phenotype categories. Mean ± SEM, normal (\>10-fold GFP nuclear enrichment) WT: 97.9 ± 1.3%, *vps4Δ*: 36.2 ± 6.5%, *cmp7Δ*: 94.1 ± 1.1%, *vps4Δcmp7Δ*: 93.2 ± 1.6%, *lem2Δ*: 86.6 ± 2.3%, *vps4Δlem2Δ*: 93.4 ± 2.0%; partial leaking (2- to 10-fold GFP nuclear enrichment) WT: 1.6 ± 0.9%, *vps4Δ*: 54.4 ± 8.1%, *cmp7Δ*: 5.9 ± 1.1%, *vps4Δcmp7Δ*: 6.8 ± 1.6%, *lem2Δ*: 11.5 ± 2.3%, *vps4Δlem2Δ*: 5.9 ± 1.4%; severe leaking (\<2-fold GFP nuclear enrichment) WT: 0%, *vps4Δ*: 9.4 ± 2.4%, *cmp7Δ*: 0%, *vps4Δcmp7Δ*: 0%, *lem2Δ*: 2.0 ± 1.3%, *vps4Δlem2Δ*: 0.7 ± 0.7%; WT: *n* = 82,56,67, *vps4Δ*: *n* = 60,59,61, *cmp7Δ*: *n* = 62,63,50, *vps4Δcmp7Δ*: *n* = 82,59,61, *lem2Δ*: *n* = 68,61,69, *vps4Δlem2Δ*: *n* = 76,50,63. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001.](pnas.1613916114fig03){#fig03}

![Time-lapse analysis of NLS-GFP-LacZ localization in *vps4Δ*. (*A*) Time-lapse images showing normal nuclear localization of NLS-GFP-LacZ converting to partial cytoplasmic localization. A pair of newly divided cells is shown over a time course of 100 min with 10-min interval. (*B*) Time lapse images showing partial cytoplasmic localization of NLS-GFP-LacZ converting to a homogenous distribution throughout the cell. A single cell is shown over a time course of 100 min with 10-min intervals. (Scale bars: 5 μm.)](pnas.1613916114sfig03){#sfig03}

*vps4Δ* NEs Are Persistently Fenestrated and Have Karmellae and Disorganized Tubular Extensions. {#s6}
------------------------------------------------------------------------------------------------

We used electron tomography of high-pressure frozen and freeze-substituted cells to examine whether we could detect morphological defects in the NE that could account for the loss of nuclear integrity. Serial 400-nm sections were imaged and reconstructed to generate 3D volumes of \>1-μm thickness. WT nuclei had evenly spaced inner and outer lipid bilayers with embedded NPCs evenly distributed around the periphery ([Fig. 4*A*](#fig04){ref-type="fig"} and [Movie S1](#d35e1617){ref-type="supplementary-material"}). *vps4Δ* nuclei, by contrast, displayed at least four structural abnormalities. First, large fenestrations through both the inner and outer nuclear membranes were observed ([Fig. 4*B*](#fig04){ref-type="fig"}, bracket). Second, karmellae or concentric layers of membrane were present around certain regions of the mutant nuclei ([Fig. 4*B*](#fig04){ref-type="fig"}, arrowheads, and [Fig. 5*B*](#fig05){ref-type="fig"}). Third, extensive whorls of disorganized tubulo-vesicular membranes that were topologically continuous with the adjacent karmellae were apparent ([Fig. 4*B*](#fig04){ref-type="fig"}, arrows, and [Fig. S4](#sfig04){ref-type="fig"}). Fourth, the total number of NPCs appeared to be decreased ([Fig. 4*B*](#fig04){ref-type="fig"}, asterisk), and the NPCs that were present were localized to regions that were largely free of karmellae and tubulo-vesicular structures ([Fig. 4*D*](#fig04){ref-type="fig"}). The 3D reconstruction of these features confirmed the presence of very large gaps (\>400 nm) in the NE and topologically continuous karmellae and whorls of tubular extensions ([Fig. 4*C*](#fig04){ref-type="fig"} and [Movies S2--S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1613916114/-/DCSupplemental)). Persistent fenestrations explain the loss of nuclear integrity in *vps4Δ* cells, whereas karmellae and other disorganized membrane extensions may underlie the kinetic delays, asymmetries, and outright failures of SPB separation and karyokinesis.

![*vps4Δ* NEs have persistent fenestrations, karmellae, and disorganized tubular extensions. (*A*, *Left*) Single tomographic slice showing the WT NE. NPCs are marked by asterisks. Segmented NE (green) with NPCs (red) reconstructed from 150 tomographic slices is shown in a merged view (*A*, *Left Center*), a front view (*A*, *Right Center*), and a side view (*A*, *Right*). (*B*, *Left*) Single tomographic slice showing the *vps4Δ* NE. The following features and defects are highlighted: a fenestration (bracket), an NPC (asterisk), karmellae layers (white arrowheads), and a disorganized whorl of tubules (arrows). (*B*, *Right*) Segmented model of NE reconstructed from 100 tomographic slices is shown in a merged view with karmellae in gold and a whorl of tubules in purple. (*C*) A segmented model of *vps4Δ* NE reconstructed from 200 tomographic slices is shown from the front (*Left*), back (*Left Center*), top (*Right Center*), and bottom (*Right*). (*D*, *Left*) Single *vps4Δ* tomographic slice showing NPCs are absent from karmellae region. The following features and defects are highlighted: a fenestration (bracket), an NPC (asterisk), and karmellae layers (white arrowheads). Segmented NE (green) with NPCs (red) and SPB (yellow) reconstructed from 150 tomographic slices shown in a merged view (*D*, *Left Center*), a front view (*D*, *Right Center*), and a side view (*D*, *Right*). (Scale bars: 200 nm.)](pnas.1613916114fig04){#fig04}

![*vps4Δ* NEs have persistent fenestrations, karmellae, and disorganized extensions, and these defects are suppressed by loss of *cmp7* or *lem2.* (*A*) WT cells with normal NE. (*B*--*D*) *vps4Δ* cells with a variety of NE phenotypes, including karmellae (*B*), multiple holes (arrows) (*C*), and discontinuities (black arrowhead) that can contain apparently intranuclear NPCs (*D*, arrowheads). (*E*--*H*) *cmp7Δ* and *lem2Δ* single mutants (*E* and *G*) vs. *vps4Δcmp7Δ* and *vps4Δlem2Δ* double mutants (*F* and *H*). (Scale bars: 500 nm.)](pnas.1613916114fig05){#fig05}

![Karmellae and tubular extension are connected NE structures in *vps4*Δ. Selected tomographic slices of *vps4Δ* show connected karmellae and tubular extensions. The relevant membranes are shaded in light green, and the junction is marked by black arrows. (Scale bar: 200 nm.)](pnas.1613916114sfig04){#sfig04}

*vps4Δ* NE Defects Are Suppressed by Loss of *cmp7* or *lem2*. {#s7}
--------------------------------------------------------------

Thin-section electron microscopy of single- and double-mutant cells demonstrated that karmellae formation in *vps4Δ* cells was completely suppressed by loss of *cmp7* or *lem2* ([Fig. 5](#fig05){ref-type="fig"}). Remarkably, double-mutant cells displayed WT-like nuclei, although a few examples of probable nuclear fenestrations were observed in *lem2Δ* single-mutant cells ([Fig. 5*G*](#fig05){ref-type="fig"}). These observations indicate that, in the absence of Vps4p, karmellae formation depends on both Lem2p and Cmp7p. Similarly, overexpressing Lem2p in *S. pombe*, or compromising nuclear import of Heh2p, an ortholog of Lem2p in *S. cerevisiae*, induces the formation of similar abnormalities ([@r31], [@r32]). Together, these results suggest that, in the absence of *vps4*, unregulated Lem2p activity drives formation of toxic NE malformations via a pathway that also requires Cmp7p ([Fig. S5](#sfig05){ref-type="fig"}).

![A cartoon model for the NE phenotypes in *vps4*Δ, *lem2*Δ, *and cmp7*Δ in *S. pombe.* (*Top*) In WT, the exposed Lem2p recruits Cmp7p to initiate an ESCRT-III--mediated NE sealing event. That process is regulated and/or completed by the AAA ATPase, Vps4p. (*Middle*) in *vps4Δ*, unrestricted Lem2p/Cmp7p activities induce the formation of karmellae and large gaps in NE so that the proper progress of mitosis is disrupted. (*Bottom*) In *lem2Δ* or *cmp7Δ*, mutant cells tolerate a limited number of small breaches and therefore show little or no growth defect.](pnas.1613916114sfig05){#sfig05}

LEM2 Recruits CHMP7 to the Reforming NE During Anaphase in Mammalian Cells. {#s8}
---------------------------------------------------------------------------

LEM2 and its homologs are two-pass membrane proteins that reside in the INM ([@r32], [@r33]). A LEM2 homolog in budding yeast, Heh2, has been previously implicated in ESCRT-dependent surveillance of defective NPCs ([@r21]). These studies and our observations suggested that LEM2-like proteins in both budding and fission yeast may be site-specific nuclear membrane adaptors that recruit and/or activate Cmp7p/CHMP7. Although a role for CHMP7 in NE closure has been reported in mammalian cells ([@r24]), its localization during the process of nuclear assembly had not been determined. To confirm that CHMP7 is indeed present at this site and to track the spatial relationship between LEM2 and CHMP7 in human cells, we assessed the dynamics of LEM2-mCherry and GFP-CHMP7 localization by live imaging of HeLa cells. Like other NE proteins that reside in the endoplasmic reticulum during mitosis ([@r34]), LEM2-mCherry was found in a reticular network as cells emerged from metaphase. Early in anaphase, LEM2-mCherry rapidly accumulated around condensed chromatin disks---first at distal ends, then concentrating at the central or "core" region of the anaphase disk, and then broadening to a distributed nuclear rim pattern. The latter pattern has been reported ([@r35]). CHMP7 recruitment to the chromatin surface coincided closely in time with the appearance of LEM2, resulting initially in their robust concentration at the same regions of the chromatin disks ([Fig. 6*A*](#fig06){ref-type="fig"}, [Movie S5](#d35e1971){ref-type="supplementary-material"}, and [Fig. S6*A*](#sfig06){ref-type="fig"}). The spatiotemporal specificity of the CHMP7 and LEM2 recruitment during early anaphase contrasts with their lack of colocalization after cleavage furrow ingression ([Fig. 6*A*](#fig06){ref-type="fig"}, [Movie S5](#d35e1971){ref-type="supplementary-material"}, and [Fig. S6*A*](#sfig06){ref-type="fig"}) and their even more distinct spatial distributions during interphase, when GFP-CHMP7 was no longer present at the chromatin surface, and LEM2-mCherry decorated the nuclear rim as expected ([Fig. S6*B*](#sfig06){ref-type="fig"}).

![Live imaging of LEM2-dependent recruitment of CHMP7 to reforming nuclei during mammalian anaphase. (*A*) Montage of a representative cell expressing LEM2-mCherry and GFP-CHMP7 progressing through anaphase before complete furrow ingression (designated as *t* = 0′). LEM2-mCherry makes initial contacts with chromatin (white arrow), and GFP-CHMP7 localizes to sites of LEM2-mCherry enrichment (*t* = −2′, −1′). (*B*) Illustrative cells, at *t* = −1′, treated with siRNA as indicated and expressing GFP-CHMP7. (*C*) Quantification of GFP-CHMP7 peaks at chromatin disks of cells treated with siRNA (mean ± SD; siControl: 12 ± 6%, *n* = 28; siLEM2-1: 5 ± 4%, *n* = 32; siLEM2-2: 3 ± 3%, *n* = 38). \*\*\**P* \< 0.001. (Scales bar: 10 μm.)](pnas.1613916114fig06){#fig06}

![LEM2 and CHMP7 colocalization is restricted to a brief window specifically during anaphase. (*A*) Additional montages of cells expressing LEM2-mCherry and GFP-CHMP7 progressing through anaphase before complete furrow ingression (designated as *t* = 0′). (*B*) Representative image of an interphase cell expressing LEM2-mCherry and GFP-CHMP7. (Scale bars: 10 μm.)](pnas.1613916114sfig06){#sfig06}

We next tested whether LEM2 is required for CHMP7 recruitment to reforming nuclei. After depletion of endogenous LEM2 with two independent siRNA oligos ([Fig. S7 *A*--*C*](#sfig07){ref-type="fig"}), GFP-CHMP7 recruitment to anaphase chromatin was notably attenuated ([Fig. 6 *B* and *C*](#fig06){ref-type="fig"} and [Fig. S8](#sfig08){ref-type="fig"}). These results were also recapitulated in a cell line expressing H2B-mCherry, confirming that CHMP7 foci are in close apposition to the chromatin surface and that this localization is impaired after LEM2 depletion ([Movies S6](#d35e2073){ref-type="supplementary-material"} and [S7](#d35e2076){ref-type="supplementary-material"}). To further evaluate the role of LEM2 in recruiting the ESCRT pathway to the reforming NE, we also tracked the localization of IST1/CHMP8 and CHMP2A, two ESCRT-III proteins that were shown to be recruited to the surface of condensed chromatin disks to promote coordinated NE closure and disassembly of spindle microtubules ([@r24]) (also see [Movie S8](#d35e2083){ref-type="supplementary-material"}). siRNA depletion of CHMP7 abrogated robust IST1/CHMP8 and CHMP2A recruitment to chromatin, as assayed by detection of endogenous protein by fixed-cell immunofluorescence ([Fig. 7 *B* and *D*](#fig07){ref-type="fig"}, [Fig. S7 *D* and *G*](#sfig07){ref-type="fig"}, and [Tables S2](#st02){ref-type="table"} and [S3](#st03){ref-type="table"}), consistent with the reported role for CHMP7 in the recruitment of CHMP4B to assembling nuclei ([@r24]). Importantly, siRNA-mediated depletion of LEM2 also strongly attenuated robust IST1/CHMP8 and CHMP2A recruitment ([Fig. 7 *A*--*D*](#fig07){ref-type="fig"} and [Tables S2](#st02){ref-type="table"} and [S3](#st03){ref-type="table"}). By contrast, depletion of the abundant INM protein SUN1 did not alter IST1/CHMP8 localization ([Fig. S7 *E*--*G*](#sfig07){ref-type="fig"}), suggesting a specific requirement for LEM2 in this pathway. To clarify the epistatic relationship between CHMP7 and LEM2, we also depleted CHMP7 and measured LEM2 recruitment to chromatin disks during anaphase. Loss of CHMP7 had no effect on levels of LEM2 recruitment ([Fig. 7 *E* and *F*](#fig07){ref-type="fig"} and [Table S4](#st04){ref-type="table"}).

![Recruitment of CHMP2A and IST1/CHMP8 during mammalian nuclear reformation depends on LEM2, whose targeting is independent of CHMP7. (*A*) Confocal images illustrating IST1/CHMP8 localization in anaphase B cells after siControl, siLEM2-1, or siLEM2-2 treatment. (*B*) Quantification of IST1/CHMP8 recruitment to chromatin disks during anaphase B. IST1/CHMP8 recruitment was scored as robust, weak, or no chromatin-associated foci. The robust category was graphed and statistical analysis was performed, comparing the siControl dataset to each depletion condition dataset (siControl: 63 ± 6%, *n* = 18, 58, 24; siLEM2-1: 0 ± 0%, *n* = 40, 44, 12; siLEM2-2: 6 ± 6%, *n* = 34, 22, 6; siCHMP7-1: 0 ± 0%, *n* = 42, 20, 12; siCHMP7-2: 0 ± 0%, *n* = 22, 20, 2). (*C*) Widefield images illustrating CHMP2A localization in anaphase B cells after siControl, siLEM2-1, or siLEM2-2 treatment. (*D*) CHMP2A recruitment to chromatin disks at anaphase B, assessed as in *B* (siControl: 70 ± 9%, *n* = 48, 48, 52; siLEM2-1: 9 ± 5%, *n* = 108, 86, 38; siLEM2-2: 11 ± 5%, *n* = 98, 52, 42; siCHMP7-1: 4 ± 1%, *n* = 78, 102, 47; siCHMP7-2: 21 ± 8%, *n* = 112, 58, 56). Analysis of parallel samples confirmed that LEM2 and CHMP7 depletion profoundly disrupted IST1/CHMP8 recruitment as before and is shown in [Fig. S7*G*](#sfig07){ref-type="fig"}. (*E*) Widefield images of cells costained for IST1/CHMP8 and LEM2 illustrates the differential sensitivity of their localization at anaphase chromatin disks after siCHMP7-1 or siCHMP7-2 treatment. Signal detected at the midzone with LEM2 antibody is likely nonspecific ([Fig. S7*A*](#sfig07){ref-type="fig"}). (*F*) Quantification of LEM2 recruitment to chromatin disks at anaphase B. Images were used for blind scoring the presence of chromatin-associated LEM2 (siControl: 95 ± 4%, *n* = 28, 35, 39; siCHMP7-1: 90 ± 6%, *n* = 18, 72, 45; siCHMP7-2: 99 ± 1%, *n* = 35, 56, 7). Analysis of parallel samples confirmed that CHMP7 depletion profoundly disrupted IST1/CHMP8 recruitment as before and is shown in [Fig. S7*D*](#sfig07){ref-type="fig"}. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001. N.S., not significant. (Scale bars: 10 μm.) All graphs plot mean ± SEM.](pnas.1613916114fig07){#fig07}

![Control experiments for knockdown analysis. (*A*) Endogenous LEM2 detected at anaphase chromatin or disks. Spinning disk confocal microscopy of representative anaphase cells 72 h after treatment with siLEM2-1 or -2 confirmed that detection of signal at the chromatin surface is specific. Signal detected at the midzone with LEM2 antibody is nonspecific, persisting after knockdown of LEM2 with two independent oligos. (*B*) Widefield microscopy of representative interphase cells comparing detection of endogenous LEM2 at the nuclear rim 72 h after treatment with siControl or LEM2-specific oligos. (*C*) Specific depletion of LEM2 and CHMP7 with respective oligos used for RNAi is confirmed by immunoblot. \# indicates a smaller protein product likely derived from CHMP7. (*D*) IST1/CHMP8 recruitment, assessed and graphed as described in [Fig. 7*B*](#fig07){ref-type="fig"}, performed in parallel with LEM2 analysis in [Fig. 7*F*](#fig07){ref-type="fig"} (siControl: 67 ± 10%, *n* = 104, 14, 40; siCHMP7-1: 0 ± 0%, *n* = 68, 26, 24; siCHMP7-2: 0 ± 0%, *n* = 24, 10, 48). (*E*) Widefield microscopy of representative interphase cells comparing detection of endogenous SUN1 at the nuclear rim 72 h after treatment with siControl or SUN1-directed oligos. (*F*) Specific depletion of SUN1 by RNAi confirmed by immunoblot. (*G*) IST1/CHMP8 recruitment, assessed and graphed as described in [Fig. 7*B*](#fig07){ref-type="fig"}, performed in parallel with CHMP2A analysis in [Fig. 7*D*](#fig07){ref-type="fig"} (siControl: 60 ± 8%, *n* = 80, 42, 48; siLEM2-1: 8.2 ± 4%, *n* = 80, 82, 30; siLEM2-2: 17 ± 7%, *n* = 120, 82, 78; siCHMP7-1: 5 ± 3%, *n* = 76, 50, 58; siCHMP7-2: 8 ± 4%, *n* = 58, 46, 48; siSUN1A: 53 ± 18%, *n* = 58, 18, 20; siSUN1B: 50 ± 7%, *n* = 78, 44, 36). All graphs plot mean ± SEM. \**P* \< 0.05; \*\**P* \< 0.01. N.S., not significant. Scale bars, 10 μm.](pnas.1613916114sfig07){#sfig07}

![LEM2 plays a role in the recruitment of CHMP7 to anaphase chromatin disks. Additional montages of cells expressing GFP-CHMP7 and treated with siRNA, as indicated, progressing through anaphase are shown. Scale bars, 10 μm.](pnas.1613916114sfig08){#sfig08}

###### 

Quantification of IST1 recruitment in mammalian cells

  IST1        [Fig. 7*B*](#fig07){ref-type="fig"}   [Fig. S7*G*](#sfig07){ref-type="fig"}   [Fig. S7*D*](#sfig07){ref-type="fig"}                                              
  ----------- ------------------------------------- --------------------------------------- --------------------------------------- ---- ---- ---- ---- ---- ----- ----- ----- -----
  siControl                                                                                                                                                                    
   Robust     56                                    76                                      58                                      63   45   67   69   60   81    71    48    67
   Weak       39                                    19                                      38                                      32   40   26   25   30   19    29    45    31
   Absent     5                                     5                                       4                                       5    15   7    6    9    0     0     7     2
  siLEM2-1                                                                                                                                                                     
   Robust     0                                     0                                       0                                       0    0    15   10   8                      
   Weak       53                                    52                                      17                                      41   60   39   47   49                     
   Absent     47                                    48                                      83                                      59   40   46   43   43                     
  siLEM2-2                                                                                                                                                                     
   Robust     0                                     18                                      0                                       6    5    16   29   17                     
   Weak       32                                    50                                      100                                     61   34   46   35   38                     
   Absent     68                                    32                                      0                                       33   61   38   36   45                     
  siCHMP7-1                                                                                                                                                                    
   Robust     0                                     0                                       0                                       0    0    8    7    5    0     0     0     0
   Weak       2                                     0                                       0                                       1    8    22   29   20   3     4     0     2
   Absent     98                                    100                                     100                                     99   92   70   64   75   97    96    100   98
  siCHMP7-2                                                                                                                                                                    
   Robust     0                                     0                                       0                                       0    0    13   10   8    0     0     0     0
   Weak       9                                     0                                       0                                       3    10   50   50   37   0     0     0     0
   Absent     91                                    100                                     100                                     97   90   37   40   56   100   100   100   100
  siSun1A                                                                                                                                                                      
   Robust                                                                                                                                36   89   35   53                     
   Weak                                                                                                                                  55   11   60   42                     
   Absent                                                                                                                                9    0    5    5                      
  siSun1B                                                                                                                                                                      
   Robust                                                                                                                                49   61   39   50                     
   Weak                                                                                                                                  45   32   56   44                     
   Absent                                                                                                                                6    7    6    6                      

Numbers reported are the percentage of chromatin disks scored as robust, weak, or absent for IST1 for each experiment (Exp.).

###### 

Quantification of CHMP2A recruitment in mammalian cells

  CHMP2A      [Fig. 7*D*](#fig07){ref-type="fig"}             
  ----------- ------------------------------------- ---- ---- ----
  siControl                                                   
   Robust     73                                    83   54   70
   Weak       23                                    17   38   26
   Absent     4                                     0    8    4
  siLEM2-1                                                    
   Robust     12                                    16   0    9
   Weak       70                                    63   61   65
   Absent     18                                    21   39   26
  siLEM2-2                                                    
   Robust     19                                    4    10   11
   Weak       64                                    50   52   55
   Absent     16                                    46   38   33
  siCHMP7-1                                                   
   Robust     6                                     5    2    4
   Weak       26                                    38   53   39
   Absent     68                                    57   45   57
  siCHMP7-2                                                   
   Robust     5                                     28   30   21
   Weak       38                                    60   57   52
   Absent     56                                    12   13   27

Numbers reported are the percentage of chromatin disks scored as robust, weak, or absent for CHMP2A for each experiment (Exp.).

###### 

Quantification of LEM2 recruitment in mammalian cells

  LEM2        [Fig. 7*F*](#fig07){ref-type="fig"}              
  ----------- ------------------------------------- ---- ----- ----
  siControl                                                    
   Present    100                                   97   87    95
   Absent     0                                     3    13    5
  siCHMP7-1                                                    
   Present    100                                   81   87    89
   Absent     0                                     19   13    11
  siCHMP7-2                                                    
   Present    100                                   96   100   99
   Absent     0                                     4    0     1

Numbers reported are the percentage of chromatin disks scored as present or absent for LEM2 for each experiment (Exp).

Finally, to determine whether LEM2 can bind directly to CHMP7, we purified full-length human CHMP7 as well as the soluble N-terminal domain (NTD) vs. C-terminal domain (CTD) of human LEM2 to homogeneity. After immobilization on Ni-nitrilotriacetic acid (Ni-NTA) beads via a fused His-SUMO tag, the C-terminal domain---but not the N-terminal domain---bound full-length CHMP7 ([Fig. S9](#sfig09){ref-type="fig"}). Thus, our imaging, siRNA depletion, and biochemical data all support the idea that LEM2 binds CHMP7 directly and serves as an adaptor that recruits CHMP7 and other downstream ESCRT-III proteins, including IST1/CHMP8 and CHMP2A, to the reforming NE during anaphase.

![The CTD of LEM2 binds full-length CHMP7 in vitro. (*A*) Protein domain structure of human LEM2. TM, transmembrane domain. (*B* and *C*) In vitro binding assay of full-length human CHMP7 with immobilized human His-SUMO-LEM2(NTD) (amino acids 1--208; *B*) and immobilized His-SUMO-LEM2(CTD) (amino acids 398--503; *C*). Samples are SDS-buffer eluates analyzed by SDS/PAGE and Coomassie staining. Note that CHMP7 showed weak unspecific binding to the resin (*B*, lane 2) that was not increased by immobilized His-SUMO-LEM2(NTD) (*B*, lane 3). In contrast, immobilized His-SUMO-LEM2(CTD), increased CHMP7 binding significantly (*C*, compare lanes 3 and 4). Finally, LEM2 (NTD) did not bind immobilized LEM2 (CTD) (*C*, lane 5), and the presence of LEM2 (NTD) did not enhance CHMP7 binding to immobilized His-SUMO-LEM2 (CTD) (*C*, compare lanes 4 and 6).](pnas.1613916114sfig09){#sfig09}

Discussion {#s9}
==========

Pioneering work on the ESCRT pathway in budding yeast led to our understanding of its roles in multivesicular body biogenesis ([@r18]), while work in human cells is leading to a broader view of ESCRT roles at a variety of different target membranes ([@r20]). Our results indicate that the role of the ESCRT pathway in closing holes in the NE is evolutionarily ancient (ref. [@r16] and this work). The different nuclear ESCRT functions (NPC surveillance, NE reformation, and SPB insertion/removal) can now be unified by the hypothesis that all of these processes generate fenestrations in the NE that are closed by the action of the ESCRT machinery (refs. [@r21], [@r23][@r24][@r25]--[@r26], and [@r36] and this study). Conserved activities include roles for nucleus-specific adaptors of the LEM domain family and the ESCRT-II/-III hybrid protein CHMP7/Cmp7p (refs. [@r21] and [@r29] and this study). This conserved pathway may likewise underlie the requirement for Src1, a LEM-domain protein in *Aspergillus nidulans*, in the formation of stable nuclei ([@r37]). This body of work suggests that LEM2 plays a specific, initiating role in coordinating membrane remodeling events, particularly during nuclear assembly, in addition to the other roles it plays as a NE resident during interphase ([@r31], [@r35], [@r38][@r39][@r40][@r41][@r42]--[@r43]).

Two LEM family members, Heh1p and Heh2p, are involved in ESCRT recruitment in *S. cerevisiae*, so multiple LEM family proteins may also be involved in recruiting ESCRT-III activities in mammalian cells. In this regard, we found that knockdown of LEM2 in HeLa cells led to a less severe IST1/CHMP8 recruitment phenotype than knockdown of CHMP7 ([Tables S2](#st02){ref-type="table"} and [S3](#st03){ref-type="table"}). It will therefore be of great interest to determine whether additional LEM-domain family members, which are present at the nascent NE ([@r44], [@r45]), also serve as ESCRT recruitment factors in human cells. Like other ESCRT-III proteins, CHMP7 can also interact with membranes, and this activity contributes to its targeting ([@r46]), so further biochemical studies will be required to elucidate how the dynamic interplay between LEM2, CHMP7, and lipids regulates the recruitment and activity of the ESCRT pathway at the nascent NE. It will additionally be informative to determine the mechanistic basis of *vps4Δ* phenotypes in fission yeast and the underlying toxicity of unrestricted Lem2p-Cmp7p activity. We speculate that in the absence of Vps4p, Lem2p--Cmp7p complexes stabilize nuclear membrane fenestrations aberrantly and/or promote NE remodeling events that---when unregulated by Vps4p---result in karmellae, large gaps, and other malformations that ultimately compromise cell division ([Fig. S5](#sfig05){ref-type="fig"}). Similarly, overexpression of Lem2p in fission yeast induces NE malformations ([@r31]), and impairment of Heh1/2p nuclear import in budding yeast induces karmellae formation ([@r32]). We predict that both of these phenotypes depend on CHMP7/Cmp7p proteins and other downstream ESCRT pathway activities. Studies of these and related activities in the future will benefit from the facile *S. pombe* genetic system for investigating how the ESCRT pathway senses and seals breaches of the envelope---a nuclear membrane integrity pathway that is conserved from yeast to human.

Materials and Methods {#s10}
=====================

Yeast Strains and Growth Medium. {#s11}
--------------------------------

*S. pombe*, diploid strain SP286 (*h+/h+, leu1-32/leu1-32, ura4-D18/ura4-D18, ade6-M210/ade6-M216*) was used for all haploid constructions. All other strains used in this study are listed in [Tables S1](#st01){ref-type="table"} and [S5](#st05){ref-type="table"}. Cells were routinely grown in YE5 rich medium \[yeast extract 0.5% (wt/vol), glucose 3.0% (wt/vol) supplemented with 225 mg/L histidine, leucine, uracil, and lysine hydrochloride, and 250 mg/L adenine\] or Edinburgh Minimal Media (EMM; Sunrise Sciences Products) with supplements described above (EMM5). Sporulation of diploids was induced by culturing cells in EMM5 without glutamate (EMMG; Sunrise Sciences Products) and supplemented as above but without uracil. Dominant drug selection was performed with YE5 supplemented with G418 disulfate (KSE Scientific) at a concentration of 200 mg/L, hygromycin B, *Streptomyces sp.* (Calbiochem) at a concentration of 100 mg/L and ClonNAT at a concentration of 100 mg/L. To prevent caramelization, YE5 was routinely prepared by leaving out glucose during autoclaving and adding it before inoculation.

###### 

Yeast strains constructed for this study

  Strain ID                                                     Genotypes                                                              Used for experiments in
  ------------------------------------------------------------- ---------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  UBSP424                                                       *h+, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*                  [Figs. 1](#fig01){ref-type="fig"}, [4](#fig04){ref-type="fig"}, and [5](#fig05){ref-type="fig"} and [Figs. S1](#sfig01){ref-type="fig"} and [S2](#sfig02){ref-type="fig"}
  UBSP425                                                       *h+, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*                  [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  UBSP426                                                       *h+, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*                  [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  UBSP461                                                       *h+, vps4Δ::natMX6, cut12-YFP::kanMX6, leu1-32, ura4-D18,*             [Fig. 1](#fig01){ref-type="fig"} and [Figs. S1](#sfig01){ref-type="fig"} and [S2](#sfig02){ref-type="fig"}
  *ade6-M216*                                                                                                                          
  UBSP462                                                       *h+, vps4Δ::natMX6, cut12-YFP::kanMX6, leu1-32, ura4-D18,*             [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *ade6-M210*                                                                                                                          
  UBSP463                                                       *h+, vps4Δ::natMX6, cut12-YFP::kanMX6, leu1-32, ura4-D18,*             [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *ade6-M210*                                                                                                                          
  UBSP464                                                       *h+, vps4Δ::natMX6, cut12-YFP::kanMX6, leu1-32, ura4-D18,*             [Figs. 4](#fig04){ref-type="fig"} and [5](#fig05){ref-type="fig"} and [Fig. S4](#sfig04){ref-type="fig"}
  *ade6-M210*                                                                                                                          
  UBSP468                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX4, cut12-YFP::kanMX6,*                 [Figs. 1](#fig01){ref-type="fig"} and [5](#fig05){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-216*                                                                                                        
  UBSP469                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX4, cut12-YFP::kanMX6,*                 [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-216*                                                                                                        
  UBSP470                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX4, cut12-YFP::kanMX6,*                 [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-216*                                                                                                        
  UBSP480                                                       *h+, cmp7Δ::hphMX4, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*   [Figs. 1](#fig01){ref-type="fig"} and [5](#fig05){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  UBSP481                                                       *h+, cmp7Δ::hphMX4, cut12-YFP::kanMX6, leu1-32, ura4-D18,*             [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *ade6-M216*                                                                                                                          
  UBSP482                                                       *h+, cmp7Δ::hphMX4, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*   [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  UBSP570                                                       *h+, lem2Δ::hphMX4, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*   [Figs. 1](#fig01){ref-type="fig"} and [5](#fig05){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  UBSP571                                                       *h+, lem2Δ::hphMX4, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M216*   [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  UBSP572                                                       *h+, lem2Δ::hphMX4, cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*   [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  UBSP590                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4, cut12-YFP::kanMX6,*                 [Figs. 1](#fig01){ref-type="fig"} and [5](#fig05){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-M216*                                                                                                       
  UBSP591                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4, cut12-YFP::kanMX6,*                 [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-M216*                                                                                                       
  UBSP592                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4, cut12-YFP::kanMX6,*                 [Fig. 1](#fig01){ref-type="fig"} and [Fig. S1](#sfig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-M216*                                                                                                       
  UBSP652                                                       *h+, ish1-mCherry::hphMX4, cut12-YFP::kanMX6, leu1-32,*                [Figs. 1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"}
  *ura4-D18, ade6-M210*                                                                                                                
  UBSP653                                                       *h+, ish1-mCherry::hphMX4, cut12-YFP::kanMX6, leu1-32,*                [Figs. 1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"}
  *ura4-D18, ade6-M210*                                                                                                                
  UBSP654                                                       *h+, ish1-mCherry::hphMX4, cut12-YFP::kanMX6, leu1-32,*                [Figs. 1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"}
  *ura4-D18, ade6-M210*                                                                                                                
  UBSP670                                                       *h+, vps4Δ::natMX6, ish1-mCherry::hphMX4,*                             [Figs. 1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M216*                                                                                    
  UBSP694                                                       *h+, vps4Δ::natMX6, ish1-mCherry::hphMX4,*                             [Figs. 1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M216*                                                                                    
  UBSP697                                                       *h+, vps4Δ::natMX6, ish1-mCherry::hphMX4,*                             [Figs. 1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M216*                                                                                    
  UBSP829                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX4, ish1-mCherry::ura4(+),*             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ade6-M216*                                                                                              
  UBSP830                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX4, ish1-mCherry::ura4(+),*             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ade6-M216*                                                                                              
  UBSP809                                                       *h+, cmp7Δ::hphMX4, ish1-mCherry::natMX6,*                             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*                                                                                    
  UBSP810                                                       *h+, cmp7Δ::hphMX4, ish1-mCherry::natMX6,*                             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*                                                                                    
  UBSP811                                                       *h+, cmp7Δ::hphMX4, ish1-mCherry::natMX6,*                             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M216*                                                                                    
  UBSP801                                                       *h+, lem2Δ::hphMX4, ish1-mCherry::natMX6,*                             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M210*                                                                                    
  UBSP803                                                       *h+, lem2Δ::hphMX4, ish1-mCherry::natMX6,*                             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M216*                                                                                    
  UBSP804                                                       *h+, lem2Δ::hphMX4, ish1-mCherry::natMX6,*                             [Fig. 1](#fig01){ref-type="fig"}
  *cut12-YFP::kanMX6, leu1-32, ura4-D18, ade6-M216*                                                                                    
  UBSP807                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4, ish1-mCherry::kanMX6,*              [Fig. 1](#fig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-M216*                                                                                                       
  UBSP808                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4, ish1-mCherry::kanMX6,*              [Fig. 1](#fig01){ref-type="fig"}
  *leu1-32, ura4-D18, ade6-M216*                                                                                                       
  UBSP831                                                       *h+,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18,*                [Fig. 3](#fig03){ref-type="fig"}
  *ade6-M216*                                                                                                                          
  UBSP832                                                       *h+,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*      [Fig. 3](#fig03){ref-type="fig"}
  UBSP833                                                       *h+,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*      [Fig. 3](#fig03){ref-type="fig"}
  UBSP896                                                       *h+, vps4Δ::natMX6, ish1-mCherry::phpMX4,*                             [Fig. 3](#fig03){ref-type="fig"} and [Fig. S3](#sfig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18,*                                                                                    
  *ade6-M210*                                                                                                                          
  UBSP900                                                       *h+, vps4Δ::natMX6, ish1-mCherry::phpMX4,*                             [Fig. 3](#fig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M210*                                                                          
  UBSP903                                                       *h+, vps4Δ::natMX6, ish1-mCherry::phpMX4,*                             [Fig. 3](#fig03){ref-type="fig"} and [Fig. S3](#sfig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M210*                                                                          
  UBSP843                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX4,*                                    [Fig. 3](#fig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*                                                                          
  UBSP844                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX6,*                                    [Fig. 3](#fig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*                                                                          
  UBSP845                                                       *h+, vps4Δ::natMX6, cmp7Δ::hphMX4,*                                    [Fig. 3](#fig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*                                                                          
  UBSP839                                                       *h+, cmp7Δ::hphMX4,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+),*           [Fig. 3](#fig03){ref-type="fig"}
  *ura4-D18, ade6-M216*                                                                                                                
  UBSP840                                                       *h+, cmp7Δ::hphMX4,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+),*           [Fig. 3](#fig03){ref-type="fig"}
  *ura4-D18, ade6-M216*                                                                                                                
  UBSP841                                                       *h+, cmp7Δ::hphMX4,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+),*           [Fig. 3](#fig03){ref-type="fig"}
  *ura4-D18, ade6-M216*                                                                                                                
  UBSP835                                                       *h+, lem2Δ::hphMX4,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+),*           [Fig. 3](#fig03){ref-type="fig"}
  *ura4-D18, ade6-M210*                                                                                                                
  UBSP836                                                       *h+, lem2Δ::hphMX4,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+),*           [Fig. 3](#fig03){ref-type="fig"}
  *ura4-D18, ade6-M210*                                                                                                                
  UBSP837                                                       *h+, lem2Δ::hphMX4,* int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+),*           [Fig. 3](#fig03){ref-type="fig"}
  *ura4-D18, ade6-M216*                                                                                                                
  UBSP842                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4,*                                    [Fig. 3](#fig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*                                                                          
  UBSP847                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4,*                                    [Fig. 3](#fig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*                                                                          
  UBSP848                                                       *h+, vps4Δ::natMX6, lem2Δ::hphMX4,*                                    [Fig. 3](#fig03){ref-type="fig"}
  int*::Pnmt1-SV40NLS-GFP-LacZ::leu1(+), ura4-D18, ade6-M216*                                                                          

Yeast Transformation. {#s12}
---------------------

Log-phase yeast cells were incubated in 0.1 M lithium acetate (pH 4.9) for 2 h, at a concentration of 5 × 10^8^ cells per mL. A total of 100 μL of this cell suspension was then mixed with 0.5--1 μg of DNA and 290 μL of 50% (wt/vol) PEG 8000 and incubated overnight. Cells were recovered in 0.5× YE5 medium overnight before plating. All steps were conducted at 32 °C.

Sporulation, Random Spore Analysis, and Tetrad Dissection. {#s13}
----------------------------------------------------------

Sporulation of *S. pombe* diploids for tetrad dissection or random spore analysis was induced by first transforming pON177 (*h*^−^ mating plasmid with ura4 selectable marker, a gift from Megan King, Yale School of Medicine, New Haven) into the parental strain. Transformants were selected on EMM5 without uracil (EMM5-uracil) for 3 d at 32 °C followed by induction in 0.5 mL of EMMG without uracil (EMMG-uracil) for 36--48 h at 25 °C. Sporulation was confirmed by microscopy. Ascus walls of tetrads were digested with 2% (vol/vol) β-glucuronidase (Sigma-Aldrich) overnight at 25 °C. This overnight treatment also eliminated nonsporulated diploids. Enrichment of spores was verified by microscopy. Fivefold to 10-fold serial dilutions were made, and spores were plated on YE5 supplemented with specific antibiotics.

For tetrad dissection, 10-fold serial dilutions of β-glucuronidase--treated tetrads were placed onto YE5 plates as a narrow strip, and digestion was monitored at room temperature. Tetrads were picked and microscopically dissected along predesignated lines of the same YE5 plate. Spores were allowed to germinate and grow at 32 °C.

Knockout Cassettes and Plasmids. {#s14}
--------------------------------

### vps4 *deletion cassette.* {#s15}

The *vps4Δ::natMX6* template ([@r16]) was amplified to create an amplicon covering 756 bp upstream of the ATG and 499 bp downstream of the stop codon. This 2,439-bp amplicon was transformed into SP286 and plated on YE5 + ClonNAT to select for heterozygous *vps4Δ::natMX6/+* diploids.

### cmp7 *deletion cassette.* {#s16}

A fragment including 420 bp upstream of the ATG and 377 bp downstream of the stop codon was amplified and cloned into BamHI/BglII and EcoRV/SpeI of pAG32 (a pFA6-derived plasmid containing *hphMX4*, which confers resistance to hygromycin B, was a gift from David Stillman, Department of Pathology, University of Utah). The *cmp7Δ::hphMX4* fragment was amplified and transformed into heterozygous *vps4Δ::natMX6/+* diploid intermediate strain and selected on YE5 supplemented with both ClonNAT and hygromycin B.

### lem2 *deletion cassette.* {#s17}

A 3.1-kb *lem2* genomic fragment spanning 600 bp upstream of the ATG to 500 bp downstream of the stop codon was subcloned into pGEM vector. The ORF region was replaced with a *hphMX4* hygromycin resistance cassette to make the final knockout construct (pMGF130). The *lem2Δ::hphMX4* cassette was amplified and transformed into heterozygous *vps4Δ::natMX6/+* diploids and selected on YE5 supplemented with both ClonNAT and hygromycin B.

### cut12-YFP *cassette.* {#s18}

A 3.5-kb synthetic DNA fragment was created that spanned 550-bp C-terminal of *cut12* fused with *YFP* followed by *kanMX6* and a 500-bp fragment downstream of the *cut12* stop codon. The fragment was transformed into heterozygous diploid strains, and the resulting diploids were selected on YE5 supplemented with G418 disulfate.

### ish1-mCherry *cassettes.* {#s19}

A 1-kb *ish1* genomic DNA fragment corresponding to 500 bp upstream and 500 bp downstream of the *ish1* stop codon was subcloned into the pGEM vector. A flexible linker (GGTGGSGGT*)* and *mCherry* fusion cassettes were assembled, followed by the *yADH1* terminator and MX4/6 drug resistance or auxotrophic markers. These cassettes were integrated at the native *ish1* locus to make the final fusion constructs: *ish1-mCherry::natMX6* (pMGF170), *ish1-mCherry*::*kanMX6* (pMGF169), *ish1-mCherry*::*hphMX4* (pMGF157), and *ish1-mCherry*::*ura4(+)* (pMGF172).

### pDual-SV40NLS-GFP-LacZ *construct.* {#s20}

A *SV40NLS-GFP-LacZ* fragment was amplified from pREP3X (provided by Shelley Sazer, Baylor College of Medicine, Houston) and subcloned downstream of the *Pnmt1* promoter in the *pDual* vector. The final construct (pMGF173) was integrated at the *leu1* locus.

### Pcmv(Δ5)-GFP-CHMP7 and pCMV(Δ5)-LEMD2-mCherry. {#s21}

*CHMP7* and *LEMD2* cDNA were amplified and subcloned downstream of Pcmv(*Δ5)* ([@r47]). GFP+linker (see as above) was inserted before *CHMP7* (pMGF182), and linker+mCherry was inserted after *LEMD2* (pMGF196) to make the fusions.

Isolation of *vps4Δ* and Suppressors. {#s22}
-------------------------------------

### *Isolation and handling of* vps4Δ *haploids.* {#s23}

Individual petite colonies from random spore analysis plates of YE5+ClonNAT were selected, resuspended in 200 μL of YE5 medium, plated onto two YE5+ClonNAT plates, and incubated at 32 °C for 3 d. Isolates that grew across one plate without apparent suppression were frozen with glycerol without further culturing by scraping and resuspension in YE5 with 15% (wt/vol) glycerol. Cells from the other plate were scraped, and genomic DNA was immediately extracted for Illumina sequencing (see below).

### *Isolation of* vps4Δ *suppressors.* {#s24}

*vps4Δ* isolates were restreaked from glycerol stocks and cultured on YE5 at 32 °C. Large colonies (apparent suppressors) were picked, resuspended in 200 μL of YE5 medium, and plated onto two YE5 plates. After 2 d, cells were harvested as described above for glycerol stocks and genomic DNA extraction.

Yeast Genomic DNA Extraction, Illumina Sequencing, and Analysis. {#s25}
----------------------------------------------------------------

### Genomic DNA extraction. {#s26}

Frozen pellets of WT, *vps4Δ*, or suppressor cells (200 μL) were thawed on ice. A total of 250 μL of resuspension buffer (20 mM Tris⋅HCl, pH 8.0, 100 mM EDTA, and 0.5 M β-mercaptoethanol) and 50 μL of lyticase (50 units) were then added to remove the cell wall. Genomic DNA was extracted by using phenol/chloroform/isoamyl alcohol, precipitated with ethanol, and treated with RNase, followed by DNeasy Blood Tissue purification according to the manufacturer's protocol (Qiagen catalog no. 69504).

### Illumina sequencing. {#s27}

Libraries were constructed by using the Illumina TruSeq DNA Sample Preparation Kit (catalog nos. FC-121-2001 and FC-121-2002). Briefly, genomic DNA was sheared in a volume of 52.5 μL by using a Covaris S2 Focused-ultra-sonicator with the following settings: intensity, 5.0; duty cycle, 10%; cycles per burst, 200; treatment time, 120 s. Sheared DNA was converted to blunt-ended fragments and size-selected to an average length of 275 bp by using AMPure XP (Beckman Coulter catalog no. A63882). After adenylation of the DNA, adapters containing a T-base overhang were ligated to the A-tailed fragments. Adapter-ligated fragments were enriched by PCR (eight cycles) and purified with AMPure XP. The amplified libraries were qualified on an Agilent Technologies 2200 TapeStation by using a D1K ScreenTape assay (catalog no. 5067-5363), and quantitative PCR was performed by using the Kapa Biosystems Kapa Library Quant Kit (catalog no. KK4824) to define the molarity of adapter-modified molecules. Molarities of all libraries were subsequently adjusted to 10 nM, and equal volumes were pooled in preparation for Illumina sequencing.

### Sequencing data analysis. {#s28}

Raw reads were aligned to the *S. pombe* genome, obtained from Ensembl Fungi, by using NovoCraft Novoalign, allowing for no repeats (-r None) and base calibration (-k). Alignments were converted to Bam-formatted files by using samtools ([samtools.sourceforge.net](http://samtools.sourceforge.net/)). Sequence pileups were generated with samtools pileup, and variants were called by using the bcftools utility (options -c -g -v). Variants were filtered by using the included varFilter Perl script included with samtools and written out as a vcf file. To distinguish unique variants in each strain from common variants, sample vcf files were intersected with one another by using the Perl script intersect_SNPs (<https://github.com/tjparnell>). Variants were annotated with the Perl script locate_SNPs (<https://github.com/tjparnell>) by using a GFF3 gene annotation file obtained from Ensembl. From the resulting table, variants were further filtered by the fraction of reads supporting the alternate allele, the presence of codon changes, and visual inspection in a genome browser. The summary statistics are reported in [Table S1](#st01){ref-type="table"}.

Fluorescence Microscopy. {#s29}
------------------------

All yeast strains were cultured in either YE5 or EMM5, if the desired protein was induced by the *nmt1* promoter. Cells were imaged after reaching log phase. Hoechst staining was conducted at a concentration of 1 μg/mL in water for 15 min. Images were collected on a Zeiss Axio Observer Z1 microscope by using a 100× oil-immersion objective.

HeLa cells were fixed in −20 °C methanol for 10 min. The primary antibodies used for immunodetection were rabbit α-IST1/CHMP8 ([@r48]), α-LEM2 (HPA017340; Sigma), rat α-tubulin (YL1/2; Accurate Chemical & Scientific), rabbit α-CHMP2A (UT 634; Covance), and mouse α-IST1/CHMP8 (UT 697; Covance). Full-length CHMP2A and IST1/CHMP8 protein ([@r49]) were used as antigens to produce custom antibodies by Covance Immunology Services. The anti-IST1/CHMP8 antibody (UT 697) was affinity-purified ([@r50]) before use. After incubation with fluorescently labeled secondary antibodies (Thermo Fisher), coverslips were mounted by using DAPI ProLong Gold (Thermo Fisher) and imaged. For the purpose of illustration, images of anaphase B cells were acquired by spinning-disk confocal microscope and adjusted so that cytoplasmic IST1/CHMP8 intensity was comparable between samples. Images acquired by widefield microscopy at 100× were used to score the IST1/CHMP8 and CHMP2A phenotypes after minimal adjustment that was applied uniformly. For each graph, IST1/CHMP8 and CHMP2A localization to anaphase B chromatin masses were assessed in three independent experiments. Each chromatin disk (two per cell) was scored as having robust, weak, or no recruitment for IST1/CHMP8 or CHMP2A. Robust recruitment was characterized by distinctive foci organized at chromatin masses, whereas weak recruitment was characterized by less intense, often fewer, and less organized foci at the chromatin surface. Images of anaphase B cells from all treatments and experiments were randomized and quantified blindly by three scorers. The majority score was used in cases where the three scores differed. In an analogous set of experiments, anaphase B cells from all treatments were scored blindly for the absence or presence of chromatin-associated LEM2. As a positive control, anaphase B cells were scored, in parallel, as having robust, weak, or no IST1/CHMP8 recruitment.

Time-Lapse Light Microscopy Analysis. {#s30}
-------------------------------------

WT and *vps4Δ* cells were grown in YE5 at 32 °C for 8 h and loaded into the CellASIC ONIX Microfluidic system (catalog no. EVE262, EMD Millipore), which immobilizes the cells in a single focal plane, maintains a constant temperature (32 °C), and pumps fresh medium over the cells. Images from multiple positions per chamber were captured every 10 min for 16 h. A lens heater was used to maintain constant temperature inside the chamber. Images were collected with an Andor Clara CCD camera attached to a Nikon Ti microscope using a 60× oil Nikon Apo Lambda S NA 1.4 lens. The samples were illuminated with a Lumencor Sola LED at 20% intensity, which was further reduced by the insertion of an ND8 filter. Exposure times ranged between 1 and 3 s for both YFP and mCherry channels. Five Z plane images separated by 1 μm were collected. Maximum intensity projection images were created to follow the Cut12p-YFP signals within a given cell. For Ish1p-mCherry signals, only the Z plane that bisected the nucleus was chosen for further image analysis.

For time-lapse colocalization experiments in HeLa cells, cells were plated on fibronectin-coated Mat-Tek dishes and incubated overnight. Cells were then transiently cotransfected with pCMV(Δ5)-GFP-CHMP7 and pCMV(Δ5)-LEM2-mCherry using Lipofectamine 3000 (Thermo Fisher) to coexpress GFP-CHMP7 and LEM2-mCherry under attenuated CMV promoters ([@r47]). For siRNA depletion and GFP-CHMP7 expression experiments, HeLa cells, either parental or stably expressing H2B-mCherry, were plated on fibronectin-coated Mat-Tek dishes in the presence of siRNA (siControl, siLEM2-1, or siLEM2-2, as described below). After 24 h, pCMV(Δ5)-GFP-CHMP7 was delivered by transient transfection with Lipofectamine 3000. In all live imaging experiments, cells were transiently transfected for 24 h before being arrested at G1/S and released, as described below. Twelve hours after release, cells were live-imaged by spinning disk confocal microscopy.

Quantification of Nuclear Enrichment of NLS-GFP-LacZ. {#s31}
-----------------------------------------------------

Fluorescence microscopy of fission yeast was performed as described above by using 0.2-s exposures for five Z-sections separated by 0.29-μm steps. Integrated pixel intensities for GFP were measured within a 100- × 100-pixel square box at both the center of nucleus and cytoplasm near the pole of the cell. The average background pixel intensity was also measured from cell-free regions of the image, and this value was subtracted from both the nuclear sum and the cytoplasmic sum. The fold nuclear GFP enrichment was calculated as the ratio of nuclear/cytoplasmic integrated intensity. A minimum of 150 cells were quantified for each genotype.

Quantification of CHMP7 Recruitment During Anaphase. {#s32}
----------------------------------------------------

Live-cell fluorescence microscopy was performed as described above. Images of cells from 1 min before cleavage furrow ingression were selected for scoring. The "Find Maxima" function with variable noise tolerance values, as implemented in ImageJ, was used to identify CHMP7 foci around the contour of chromatin disks in each cell. The absolute number of those foci were recorded and scored blindly between siControl and siLEM2.

Electron Microscopy. {#s33}
--------------------

Yeast strains were grown to log phase and harvested by using gentle vacuum filtration onto filter paper. The cell pellet was scraped from the filter, mixed with cryoprotectant \[20% (wt/vol) BSA in PBS\], transferred to the well of a 100-µm specimen carrier (type A), and covered with the flat side of a type B specimen carrier ([@r51]). The loaded specimens were immediately frozen with a high-pressure freezer (EM-HPM100; Leica Microsystems). Frozen cell were transferred for freeze substitution (FS) to a precooled Leica AFS unit (Leica Microsystems) and processed in the following substitution solution: 97% anhydrous acetone (EMS, RT10016) and 3% of water, 2% osmium tetroxide, and 0.1% uranyl acetate. Substitution started at --90 °C for 72 h, followed by a gradual increase in temperature (5 °C/h) to −25 °C over 13 h, held at −25 °C for 12 h, then warmed (10 °C/h) to 0 °C over 2.5 h). The samples were removed from the AFS unit, washed six times with pure acetone, and gradually infiltrated and embedded in Epon12-araldite resin as follows: 50% (vol/vol) epon12-araldite/acetone overnight, 75% (vol/vol) epon12-araldite/acetone for 24 h, 100% epon12-araldite for 8 h, and polymerized at 60 °C for 48 h. Ultrathin sections (70 nm) were cut by using a diamond knife (Diatome), using a UC6 microtome (Leica Microsystems), transferred to Formvar- and carbon-coated mesh copper grids (Electron Microscopy Sciences; FCF-200-Cu) and poststained with 3% (wt/vol) uranyl acetate and Reynold's lead citrate. The sections were viewed with a JEM-1400 Plus transmission electron microscope (JEOL, Ltd.) at 120 kV and images collected on a Gatan Ultrascan CCD (Gatan, Inc.).

Electron Tomography. {#s34}
--------------------

Blocks of embedded WT and *vps4Δ S. pombe* cells were trimmed to ∼100- × 200-μm faces. Serial semithick (400 nm) sections were cut with a UC6 Ultramicrotome (Leica Microsystems) by using a diamond knife (Diatome Ltd.). Ribbons of 10--20 sections were placed on Formvar-coated, copper-rhodium, 1-mm slot grids (Electron Microscopy Sciences) and stained with 3% (wt/vol) uranyl acetate and Reynold's lead citrate. Colloidal gold particles (10 nm) were placed on both surfaces of the sections to serve as fiducial markers for subsequent tomographic image alignment, and the grids were carbon-coated to enhance stability in the electron beam.

Grids were placed in a dual-axis tomography holder (model 2040; EA Fischione Instruments, Inc.) and imaged with a Tecnai TF30-ST transmission electron microscope (FEI Company) equipped with a field emission gun and operating at 300 kV. Well-preserved cells displaying structures of interest were identified and tracked over 6--10 serial sections. The volume of the cell present in each section was then imaged as a dual-axis tilt series; for each set, the grid was tilted ± 64°, and images were recorded at 1° intervals. The grid was then rotated 90°, and a similar series were recorded about the orthogonal axis. Tilt-series datasets were acquired automatically by using the SerialEM software package ([@r52]), and images were recorded with a XP1000 CCD camera (Gatan, Inc.). Tomographic data were calculated and serial tomograms were joined together by using the IMOD software package ([@r53][@r54]--[@r55]). Tomograms were analyzed, segmented, and modeled by using IMOD. The NE was traced with closed contours in each tomogram. Modeled contours were smoothed and 3D surfaces were generated with tools in the IMOD software package. The "Z inc" value was set to three for all NE objects to further smooth their surface. The number of serial semithick (400-nm) sections used for model segmentation and display were three for WT ([Movie S1](#d35e1617){ref-type="supplementary-material"}), two for *vps4Δ* ([Movie S2](#d35e4677){ref-type="supplementary-material"}), four for *vps4Δ* ([Movie S3](#d35e4683){ref-type="supplementary-material"}), and three for the second *vps4Δ* ([Movie S4](#d35e4689){ref-type="supplementary-material"}).

siRNA-Mediated Depletion and Cell-Cycle Synchronization. {#s35}
--------------------------------------------------------

HeLa cells were plated on fibronectin-coated coverslips in the presence of 10 nM siRNA oligo, delivered by Lipofectamine RNAiMAX Transfection Reagent (Thermo Fisher). Specific sequences used were: siControl \[siScr-1 ([@r56])\], siLEM2-1 \[antisense sequence targeting nucleotides 78--98: UUGCGGUAGACAUCCCGGGdTdT ([@r43])\], siLEM2-2 \[antisense sequence targeting nucleotides 1,297--1,317: UACAUAUGGAUAGCGCUCCdTdT ([@r43])\], siCHMP7-1 \[CHMP7 650; sense sequence: GGGAGAAGAUUGUGAAGUUdTdT ([@r22])\], and siCHMP7-2 \[CHMP7 613; sense sequence: CAGAAGGAGAAGAGGGUCAdTdT ([@r22])\], siSUN1A \[SUN1; sense sequence targeting nucleotides 2,321--2,345 of SUN1, transcript variant 1 (NM_001130965.2): CCAUCCUGAGUAUACCUGUCUGUAUdTdT ([@r57])\], and siSUN1B \[SUN1; sense sequence targeting nucleotides 865--883 of NM_001130965.2: UUACCAGGUGCCUUCGAAAdTdT ([@r58])\]. Culture medium containing 2 mM thymidine was then added for 24 h to arrest cells at G1/S. Cells were then rinsed thoroughly with PBS, followed by the addition of culture media. Twelve hours after release, cells were imaged live or fixed for microscopy. To verify efficacy and specificity of siRNA treatments, HeLa cells were plated in six-well dishes and subjected to similar conditions as above. Cell lysates were then harvested and analyzed with immunoblots. After incubation with primary antibodies \[α-LEM2 (HPA017340; Sigma-Aldrich), α-CHMP7 (HPA036119; Sigma-Aldrich), α-tubulin (YL1/2), and α-SUN1 (EPR6554; Abcam)\], reactivity was detected by using HRP-coupled secondary antibodies (Thermo Fisher) and chemiluminescence.

Protein Expression and Purification. {#s36}
------------------------------------

We individually expressed full-length human CHMP7 (Uniprot ID Q8WUX9) and the terminal domains of LEM2, encoded by *LEMD2* (NTD 1-208, CTD 395--503; Uniprot ID Q8NC56) with a N-terminal His~6~-Sumo affinity tag by using a pCA528 vector (WISP08-174; DNASU Plasmid Repository) in BL21-(DE3)-RIPL *Escherichia coli*. The cells were grown in autoinduction medium ZYP-50529 (1.5 L cultures each). Cells were grown at 37 °C to OD 0.8 with vigorous shaking in baffled flasks, moved to 19 °C and grown for an additional 19 h. Cells were then harvested by centrifugation, and bacterial pellets were snap-frozen in liquid nitrogen. Subsequent purification steps were performed at 4 °C. Cells were thawed and lysed for 30 min with lysozyme in 2.5 times the pellet volume of lysis buffer followed by sonication. The supernatant was clarified by centrifugation (40,000 × *g*, 45 min).

### CHMP7 *purification.* {#s37}

A total of 20--30 g of bacterial pellet were lysed (50 mM Tris, pH 8.0, 1 M NaCl, 20 mM imidazole, 10% (wt/vol) glycerol, 5 mM beta-mercaptoethanol (BME), 0.1% Triton X-100, 2 µg/mL DNase1, and protease inhibitors (84 µM leupeptin, 0.3 µM aprotinin, 1 µM pepstatin, 100 µM phenylmethylsulfonyl fluoride (PMSF)), and incubated with Ni-NTA agarose beads (Qiagen) for 2 h. The bound protein was washed with 20 column volumes (CVs) of lysis buffer without lysozyme and protease inhibitors, 20 CVs of wash buffer \[50 mM Tris (pH 8), 1 M NaCl, 20 mM Imidazole, 5% (wt/vol) glycerol, 5 mM BME, and 0.009% Triton X-100\] and eluted in four steps (1 CV per step) with wash buffer supplemented with increasing imidazole concentrations (50, 150, 250, and 400 mM). The eluted protein was dialyzed for 2 h against gel filtration buffer \[50 mM Tris, (pH 8.0), 150 mM KCl, 1 mM DTT, 5% (wt/vol) glycerol\]. Ulp1 protease (0.75 mg per 30 mL) was added to the dialysis bag to remove the affinity tag, and the dialysis reaction was performed overnight. The cleaved protein was incubated with 2 mL of Ni-NTA agarose beads (Qiagen) to remove His~6~-Sumo and Ni-NTA agarose binding contaminants. The eluate was concentrated to 5 mL with a Viviaspin 20 \[30,000 nominal molecular weight cutoff (MWCO), polyethersulfone (PES) membrane\]. Monomeric Chmp7 was isolated by gel filtration chromatography. Monomeric Chmp7 was concentrated to 24--42 µM by using a Viviaspin 20 concentrator (30,000 nominal MWCO, PES membrane), aliquoted, and snap-frozen in liquid N~2~. For binding experiments, the protein was thawed on ice and cleared from aggregates by centrifugation for 20 min at 98,600 × *g*, using a TLA-55 rotor (Beckman Coulter). Yields were 300--500 µg of protein per 1 L of bacterial culture.

### LEM2(NTD) purification. {#s38}

A total of 18 g of bacterial pellet was lysed (25 mM Tris, pH 7.0, 500 mM KCl, 10 mM imidazole, 5 mM BME, 2 µg/mL DNase1, and protease inhibitors) and incubated with Ni-NTA agarose beads (Qiagen) for 2 h. The bound protein was washed with 40 CVs of lysis buffer without lysozyme and protease inhibitors and eluted in four steps (1 CV per step) with lysis buffer supplemented with increasing imidazole concentrations (50, 150, 250, and 400 mM). The eluted protein was dialyzed against SP column loading buffer (25 mM Tris, pH 7.0, 150 mM KCl, and 1 mM DTT), applied to a 5-mL HiTrap SP HP column (GE Healthcare), washed with loading buffer, and eluted with a gradient from 150 to 500 mM KCl. The eluate was concentrated to 5 mL with a Viviaspin 20 (10.000 KDa MWCO, PES), and monomeric His-Sumo-LEM2 (NTD) was isolated by gel filtration chromatography (25 mM Tris, pH 7.0, 150 mM KCl, and 1 mM DTT). Monomeric His-Sumo-LEM2 (NTD) was concentrated to 20 µM, and aliquots were snap-frozen in liquid N~2~. Yields were ∼2.5 mg of protein per 1 L of bacterial culture. For binding experiments, His-Sumo-LEM2 (NTD) was thawed on ice and spun for 10 min at 4 °C at 16,627 × *g*. The protein was used directly for binding or processed into untagged LEM2 (NTD). To obtain untagged protein, 250 µg of His-Sumo- LEM2 (NTD) were incubated with 30 µg of Ulp1 for 1 h at 4 °C and subsequently incubated with 100 µL of Ni-NTA agarose beads (Qiagen) to remove cleaved His~6~-Sumo. The beads were removed by centrifugation, and the supernatant was used for binding experiments.

### LEM2(CTD) purification. {#s39}

Cells were suspended in buffer with 50 mM Tris (pH 8.0), 150 mM KCl, and 1 mM DTT plus protease Inhibitor mixture and were lysed by freeze--thaw cycles, and the supernatant was harvested after 16,350 × *g* for 45 min. The lysate was incubated with Ni-beads (Qiagen) for 45 min, washed with 20 mM imidazole, and eluted with 750 mM imidazole. The eluted protein was dialyzed against gel-filtration buffer (50 mM Tris, pH 8.0, 150 mM KCl, and 1 mM DTT) and applied to 120 mL of Hiload Superdex 75PG (GE Healthcare). Fractions containing pure LEM2-CTD were collected and snap-frozen in liquid nitrogen. Yields were ∼2.5 mg of protein per 1 L of bacterial culture.

Protein Binding Experiments. {#s40}
----------------------------

Binding experiments were performed at room temperature by using 40 µL of Ni-NTA agarose beads (Qiagen) in 0.8-mL centrifuge columns (Pierce). Proteins were mixed and incubated for 1 h. For control reactions, proteins were incubated with corresponding buffers to mimic binding conditions. The protein reactions were added to the beads, which were equilibrated with binding buffer (25 mM, Tris pH 7.0, 150 mM KCl, and 20 mM imidazole) and incubated for an additional 45 min. The resin was washed with 20 CVs of binding buffer. Excess His-Sumo-tagged-LEM2 (CTD or NTD) was eluted with 3 CVs of binding buffer supplemented with 150 mM imidazole. Note that the majority of LEM2 and bound CHMP7 did not elute at this step. Protein remaining on beads was eluted with two CVs of 2× SDS sample buffer and the eluate was analyzed with SDS/PAGE.

Note. {#s41}
-----

While our study was under review, corroborative evidence for these roles for CHMP7 in human cells ([@r46]) and LEM domain family proteins in budding yeast were also published by others ([@r59]).
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